EVENTS
Home » News / Events
AD/PD 2025
Find out how our preclinical EEG expertise can accelerate the development of novel anti-seizure medications.
Neuroscience 2024
We will be presenting 4 posters: qEEG – 3 vigilance states, Sleep architecture, Direct electro-stimulation, EEG phenotyping of aged mice.
Synapcell is off to California for a roadshow!
Meet us on the roadshow or at Bio 2024!
EILAT XVII
We will present an in-depth report on new anti-epileptic drugs at different stages of development, and new findings on second-generation treatments.
ASENT 2024 – American Society for Experimental Neurotherapeutics
We will be presenting a poster about “Decoding therapeutic signatures: the contribution of pharmaco-EEG in profiling compounds with varied mechanisms of action.”
CNS Therapeutics XChange 2023 in Zurich
Join us at the round table “How to prepare a clinical phase 1 by doing the right preclinical studies?” – What are the goals of a clinical phase 1? – Can we transpose the tools...
Society for Neuroscience 2023 Congress
Meet SynapCell team at Neuroscience 2023 and discover our 5 new posters.
Japan 2023
Discover our poster about EEG phenotyping of a rat model of fragile X syndrome
CNS Therapeutics XChange 2023 West Coast
Join us at the roundtable about “How can EEG and novel cutting-edge techniques transform the way drug candidates are developed until clinical phase?”
Epilepsy Therapies & Diagnostics Development (ETDD)
Don’t miss SynapCell talk about “CUE® platform by SynapCell, an EEG-based preclinical platform dedicated to ASMs from small molecules to gene therapies.”
CNS Therapeutics XChange 2023 East Coast and Essential Tremor Congress
On the agenda: poster, keynote and round table
ASENT 2023
SynapCell is proud sponsor of ASENT 2023
Society for Neuroscience 2022 – San Diego
synapcell exhibitor at society for neuroscience Society for Neuroscience is back in person, and we are thrilled to meet you there ! Each year SfN strives for scientists from around the world to congregate to...
BioJapan 2022
BIOJAPAN 2022 Biotech & Pharma Week in Japan Oct. 11-14, 2022 SynapCell is proud to participate to the French Healthcare Days @ BioJapan 2022, the leading partnering event for the biotech and life sciences industry in...
CNS Therapeutics Xchange 2022 – US West Coast
SYNAPCELL SPONSORS THE CNS XCHANGE 2022 HubXchange’s West Coast CNS Therapeutics Xchange 2022, brings together executives from pharma and biotech to address and find solutions to the key issues faced in developing CNS therapies.Discussion topics...
NEUROSCIENCE EVENTS IN PARIS, JULY 2022
FENS 2022 Federation of European Neuroscience Societies FENS – federation of European Neuroscience Societies Over 7,500 international neuroscientists, full in-person meeting, from 9th to 13th of july in paris. Eloise Gronlier will be presenting her...
EILAT XVI CONFERENCE ON NEW ANTIEPILEPTIC DRUGS & DEVICES
16th EILAT Conference on New Antiepileptic Drugs and Devices SynapCell will attend the 16th EILAT Conference on New Antiepileptic Drugs and Devices, this year occuring in Madrid. Corinne ROUCARD, CEO and co-Founder will present you...
ADPD 2022: EEG Biomarkers used to evaluate Anti-Dyskinetic effect of drugs in Parkinson’s Disease
ADDRESSING LDOPA INDUCED DYSKINESIA IN PARKINSON'S: POSTER COMMUNICATION Thanks to the use of Electroencephalography (EEG) technics, a hyper synchronization of the beta rhythms in the cortico-basal ganglia loop has been observed in both parkinsonian patients...
ASENT 2022
SynapCell sponsors the ASENT 2022 Annual Meeting The Annual American Society for Experimental Neurotherapeutics (ASENT) goes live Feb 28 until 03 March this year. Join our experts for live discussions and Q&A sessions around scientific...
AES 2021: Partnership with OVID Therapeutics in Epilepsy
The American Epilepsy Society Annual Meeting WWW.AESNET.ORG The American Epilepsy Society Annual Meeting is taking place in Chicago this year from 3-7 December 2021. SynapCell is proud to announce its partnership with OVID Therapeutics featuring...
CNS Therapeutics Xchange 2021
Proud to be Sponsoring the CNS Therapeutics HubxChange This year HubxChange Europe will welcome over 60 executive participants from Pharmas and Biotechs in a broad range of disciplines (Neurology, Neuroscience, Clinical Development, Translational science ),...
Society for Neuroscience 2021
Celebrating 50 years of the Society for Neuroscience The Society for Neuroscience will go 100% virtual this year.SfN’s mission to advancing and advocating for scientific exchange, as well as educating the public about the importance...
IPEG 2021. A Virtual Event
INTERNATIONAL PHARMACO EEG SOCIETY – IPEG2021 SynapCell is proud to participate to the International Pharmaco-EEG Society’s event: IPEG2021. Learn more about evoked responses by electrical brain stimulation with our brand new technology platform to study...
BioJapan 2021 & more!
BIOTECH WEEK IN JAPAN SynapCell is proud to participate to BioJapan 2021, the leading partnering event for the biotech and life sciences industry in Asia. Specialized in Central Nervous System, SynapCell contributes to discovering new...
Webinar: Parkinson’s disease
Parkinson’s disease Webinar SPOT THE SIGNS Parkinson’s disease represents a major burden affecting over 1% of people aged over 60. With no cure available to date to slow down or stop disease progression, current treatment options...
AEDD TRIALS XVI
SynapCell to present at AEDD TRIALS XVI June 16-18 2021 Lost in translation? Meet the GAERS! Join top experts in epilepsy at this not-to miss epilepsy-focused (e-)gathering in Pennsylvania bringing together representatives from academia, industry,...
ASENT 2021
SynapCell sponsors the ASENT 2021 Annual Meeting The Annual American Society for Experimental NeuroTherapeutics (ASENT) goes live Feb 22-25 this year. We are proud to showcase our latrest advances in EEG Phenotyping and Parkinson’s Research...
BioJapan 2020
We are thrilled to announce our participation to BioJapan this year! Due to the global Covid-19 pandemic and unability to travel,SynapCell has put Japan as a top priority of its development and has been building...
Something BIG to happen at SfN19 !
SfN 2019 is approaching! We are thrilled to be part of SfN19 in Chicago on Oct. 19-23 with great science to present. Plans to attend? Come discover our latest findings in Parkinson’s disease and more. ...
SWISS BIOTECH DAY 2019
Meet our scientists in Basel Did you know that Electro-Encephalography (EEG, EPhys) has the power to secure your Ph2 Efficacy phase as soon as at the preclinical step?This is all about predictive, objective and clinically-relevant...
AD/PD 2019 – Phase-amplitude coupling as a new biomarker of PD
Phase-amplitude coupling as a new biomarker of PD Discover the science behind at the #ADPD meeting in Lisbon this month TRANSLATIONAL NEUROSCIENCE Friday March 29662: IDENTIFICATION OF A SPECIFIC PHASE-AMPLITUDE COUPLING IN A RAT MODEL...
ASENT 2019 – From EEG signatures to predictive biomarkers
EEG biomarkers to improve the discovery of new neurotherapeutics From EEG signatures to predictive biomarkers. Learn how to accelerate lead selection with objective, measurable and reproducible readouts on preclinical efficacy programs.Don’t miss our Poster communication...
SynapCell at the Michael J. FOX Parkinson’s disease conference
The Michael J. Fox Foundation for Parkinson’s Research conference Meet Corinne Roucard Oct 25 at The Michael J. Fox Foundation for Parkinson’s Research conference in NYC and learn more on the use of predictive EEG Biomarkers...
BioJapan 2018, Yokohama
BioJapan is approaching! Our team is heading to Osaka on October 9 for the B2Match partnering event and to Yokohama October 10-12 for BioJapan2018.A unique occasion to meet with leading researchers from Japan and share...
SFN 2018 – Major milestones achieved
SfN 2018 in San Diego We’ll exhibit at SfN 2018 in San Diego!2018 has been rich in innovations thanks to unprecedented R&D efforts in the lab.The team will present 3 posters that describe how EEG...
BIO2018, Boston
BIO2018
Meet the team and discover how we help solve uncertainty with our translational PharmacoEEG programs and predictive biomarkers for CNS Drug Discovery.
Meet SynapCell at EILAT XIV
14th EILAT Conference on New Antiepileptic Drugs SynapCell will participate to the 14th EILAT Conference on New Antiepileptic Drugs and Devices in Madrid May 13-16. This will be the occasion for us to announce the renewal of SynapCell...
SynapCell at AD/PD 2017
AD/PD 2017 Conference Dear all,We are pleased to announce that we will present our latest advances in Parkinson’s Disease and Dyskenesia during the AD/PD 2017 Conference.We look forward to meeting with you there! POSTER #320Amantadine decreases...
MDS 2016 – Let’s meet in Berlin !
Parkinson’s and Essential Tremor’s Drug Discovery program Our experts will present 2 Posters on the use of EEG Biomarkers, that are both Predictive and Translational for your Parkinson’s and Essential Tremor’s Drug Discovery program.We’re looking forward to meeting...
EILAT XIII CONFERENCE: Attending ?
13th EILAT Conference SynapCell will attend the 13th EILAT Conference on New Antiepileptic Drugs and Devices!Corinne ROUCARD, CEO and co-Founder will present you how the MTLE model provides an efficient way to identify new treatment for drug-resistant...
NEUROSCIENCE 2015 – Let’s meet in Chicago !
Neuroscience 2015 Coming up in a month in Chicago, Neuroscience 2015 is the world’s largest source of emerging news on brain science and health, with more than 30,000 attendees! Lectures, symposia, and thousands of posters provide new understanding of how...
NEUROSCIENCE 2015 – Stop Guessing
Neuroscience 2015 in Chicago Stop guessing; think outside the box with EEG! We can help you select the most effective lead right from the earliest phase, avoiding time-consuming and costly trials. Strong of our 10 years...
NEURINOX SYMPOSIUM 2015
Innovative Concepts for Treating Neurodegenerative Diseases SynapCell is involved in the funded EU Project NEURINOX. Together with the project consortium, we will be hosting a symposium on Innovative Concepts for Treating Neurodegenerative Diseases. This will be held...
28TH ECNP Congress
At the end of the summer, SynapCell is going to take part of the major event in neuropsychopharmacology: the annual ECNP congress, held this year in Amsterdam. Established in 1987 at the instigation of European scientists, ECNP is committed to...
Twelfth EILAT Conference on New Antiepileptic drugs
the twelfth Eilat Conference Relocated in Madrid, Spain, August 31 – September 3 for this forthcoming edition, the twelfth Eilat Conference on new antiepileptic drug (AEDs) will be introducing debates as a new feature. These...